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Abstract: Meningitis is usually produced by an infectious agent, but there are multiple 
  noninfectious causes. Drug-induced aseptic meningitis (DIAM) is an important entity and has 
been reported as an uncommon adverse reaction with numerous agents. Thus, DIAM constitutes a 
diagnostic and patient management challenge. We present a patient with three episodes of aseptic 
meningitis due to amoxicillin, and then review the literature on this rare idiosyncratic event which 
may occur after local or systemic drug administration. A 77-year-old man was admitted to our 
hospital with fever, headache, and neck stiffness. Seven days before admission he had a dental 
and gingival inflammation. He was treated with two oral doses of 500 mg daily of amoxicillin 
for one week. The seventh day he awoke with the complaints that prompted hospital admittance. 
Amoxicillin was stopped 1 day before his admission. From his history we knew of two similar 
episodes: The first episode was after a dental procedure 3 months before this incident. He had 
received a 1-week course of postprocedure amoxicillin of 500 mg daily and had similar headache, 
fever, and chills during the entire course of treatment. He wasn’t admitted to the hospital, because 
he stopped taking amoxicillin and he felt spontaneous pain relief after taking symptomatic pain 
treatment. The second episodes was 6 months after his first admission, he had been admitted to 
our hospital with the same symptoms. Amoxicillin was stopped and changed with intravenous 
(IV) ceftriaxone (CTRX) for 10 days due to suspected partial untreated meningitis. The patient 
improved rapidly within 2 days and was discharged from the hospital. On the basis of these 
three confirmed episodes of meningitis after recurrent exposure to amoxicillin, with repetitive 
negative testing for viral, bacterial, and mycobacterial micro-organisms, we diagnosed aseptic 
meningitis induced by amoxicillin. To our knowledge, this is the seventh well documented 
publication of such a severe side effect of a commonly used antibiotic.
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Introduction
Aseptic meningitis is a central nervous system infection that encompasses all types 
of leptomeninges inflammation of the brain, characterized by fever and meningeal 
symptoms with moderate, predominantly lymphocytic cerebrospinal fluid (CSF) 
pleocytosis and with bacteriologically sterile cultures.1,2 Aseptic meningitis is not 
caused by pyogenic bacteria, but can be caused by various conditions including infec-
tious viral and nonviral,2–7 drugs, malignancy, and systemic illnesses.8 Therefore, 
this term is no longer tantamount with viral meningitis, although the two often are 
used interchangeably.8
Largely, viral infection is the most common form of aseptic meningitis and 





enteroviruses are more likely to cause meningitis outbreaks,10 
while others are mostly endemic.9 Other viral agents include 
the herpesviruses;9 human immunodeficiency virus (HIV) 
which causes sterile meningitis;11,12 and mumps13,14 are 
sometimes involved.
However, aseptic meningitis occurs at all ages, especially 
during summer and early fall,15–17 without racial differences.3 
The illness tends to occur three times more in males than in 
females.8 The incidence of aseptic meningitis in the US has 
been reported as 11 per 100,000 person-years, compared to 
8.6 per 100,000 for bacterial meningitis.18,19 The illness is 
responsible for 26,000–42,000 hospitalizations each year in 
the US,20,21 and for 37 incidence cases per 10,000 hospital 
admissions among children in Singapore.22 The severity of 
the clinical picture can be divided according to the   primary 
brain structure involved. When the infectious agent   primarily 
attacks the brain parenchyma, the clinical picture of severe 
encephalitis will be encountered with seizures, loss of con-
sciousness and obtundation. When the inflammation is pri-
marily of the meninges, a relatively milder syndrome of viral 
or aseptic meningitis is performed. In this case it is usually 
considered a benign disease,23 because of the low complica-
tions and complete recovery; most people exposed to these 
viruses experience either no symptoms or mild symptoms, 
and they usually experience full recovery in 5–14 days after 
onset of symptoms.8 However, fatigue and lightheadedness 
may persist longer in some people. Hence, there is a patho-
logical and clinical linkage between the brain parenchyma 
and meninges and some degree of meningeal inflammation is 
found with encephalitis and vice versa. When the two struc-
tures are involved a mixed picture of meningoencephalitis 
is more appropriate and the prognosis is less encouraging. 
Diagnosis is by exclusion of an infectious agent and other 
noninfectious causes such as central nervous system tumors, 
metastatic carcinomas, sarcoidosis, systemic lupus erythema-
tosus (SLE) and granulomatous angiitis, and by demonstrat-
ing a convincing temporal relationship between the time of 
ingestion of drugs and the onset of the patient’s symptoms. 
The recurrence of symptoms after rechallenge strongly 
supports the diagnosis of drug-induced aseptic meningitis 
(DIAM). Our patient developed a nearly   identical clinical 
picture consistent with DIAM on two separate occasions 
and a picture of meningoencephalitis on the third episode 
shortly after the consumption of amoxicillin. However, 
our case strongly suggests that the description of menin-
goencephalitis is more appropriate in view of the presence 
of confusion, unresponsiveness, psychomotor slowness, 
cognitive disturbances, nuchal rigidity and unilateral right 
mild weakness of the limbs without pyramidal signs. Hence, 
a high index of suspicion is needed to make an accurate 
diagnosis of DIAM.
Description of our case report 
of amoxicillin-induced aseptic 
meningitis
DIAM is an important entity. This descriptive study comes to 
shed light on the literature reviews on this rare idiosyncratic 
event which may occur after local or systemic drug admin-
istration; and presents the seventh worldwide case report of 
amoxicillin-induce aseptic meningitis.
We describe a clinical case of a patient whom we believe 
to have had amoxicillin-induced aseptic meningitis after 
receiving informed written consent form and authorization 
for publication. A 77-year-old male was admitted to our 
hospital with a history of 7 days of headache, chills, fever, 
and nuchal rigidity. The headache was pressure-like, global, 
and progressive. There was associated mild phonophobia 
but no photophobia, vomiting, nausea, or other constitu-
tional symptoms. He was treated before his admission by 
amoxicillin using two oral doses of 500 mg daily for 1 week 
following dental and gingival inflammation, the seventh 
day he awoke with the complaints that prompted   hospital 
  admittance. One day before his admission he stopped 
amoxicillin treatment.
At his admission, past clinical history, physical exami-
nation, laboratory, lumbar puncture, and computed tomog-
raphy (CT) were performed. In his past history the patient 
had a similar syndrome after a dental procedure a 3 months 
before this incident. He had received a 1-week course of 
  postprocedure amoxicillin of 500 mg daily and had   similar 
headache, fever, and chills during the entire course of 
  treatment. He wasn’t admitted to the hospital, because he 
stopped taking amoxicillin and he felt spontaneous pain relief 
after taking symptomatic pain treatment.
On examination, the patient had an oral temperature of 
38.1°C, with mild tachycardia (heart rate, 102 beats per min). 
Neurological examination revealed normal findings, includ-
ing a normal mental status, supple neck, and absent Kernig’s 
and Brudzinski’s signs. Results of examinations of other 
systems (cardiac; respiratory; head, eyes, ears, nose, and 
throat; and skin) were all normal.
The patient’s serum white blood cell (WBC) count was 
11,900 cells/mL (normal range, 3600–11,200 cells/mL), 
with a differential of 79.6% neutrophils (normal range, 
44%–88% neutrophils) and 11.4% lymphocytes (normal 





within normal limits. Lumbar puncture revealed a pleocytosis 
with 20 cells (80% mononuclear), raised protein concentra-
tion of 91 mg/dL and glucose level was normal. No bacterial, 
fungal micro-organism or serological signs of viral infection 
had been found. Herpes simplex polymerase chain reaction 
and enterovirus CSF polymerase chain reaction (PCR) were 
negative. CT of the brain was normal and it was performed 
for excluding alternative diagnosis in certain situations. 
Amoxicillin was stopped and changed with intravenous (IV) 
ceftriaxone (CTRX) for 10 days due to suspected partial 
untreated meningitis. The patient improved rapidly within 2 
days and was discharged from the hospital.
Six months after his first admission, he was admitted 
again with severe complaints of: headache, confusion, 
unresponsiveness, psychomotor slowness, cognitive distur-
bances, nuchal rigidity, and unilateral right mild weakness 
of the limbs without pyramidal signs and oral temperature of 
38.3°C. The patient’s son proclaimed that his father was under 
amoxicillin treatment for 4 days following a tooth   problem, 
and had a fever 1 day after initiation the treatment.
On examination our patient showed psychomotor slow-
ness, cognitive disturbances, nuchal rigidity and unilateral 
right mild weakness of the limbs without pyramidal signs. 
Lumbar puncture revealed a pleocytosis with 12 cells (70% 
mononuclear), raised protein concentration of 117 mg/dL, 
and normal range of glucose. CT of the brain was normal 
and electroencephalography (EEG) showed intermittent 
  diffuse slow waves abnormality in the theta range.   Laboratory 
examination showed no micro-organisms had been found. 
Drug-induced meningoencephalitis was considered and 
amoxicillin administration was stopped immediately. Control 
Lumbar puncture after 2 days of admission was performed 
and showed 80 WBC (86% mononuclears) and proteins level 
were 96 mcg/dL. The patient improved without any specific 
treatment, his general condition including mental status and 
a focal neurological sign improved significantly and after 
6 days was discharged. Three weeks later the patient under-
went complete medical examinations including CSF and 
cognitive exams, all the exams were normal.
According to these three repeated episodes, in which 
two were confirmed to be aseptic meningitis after repeti-
tive negative culture results for viral, bacterial and fungal 
micro-organisms, and resolved with cessation of amoxicillin 
therapy, amoxicillin was the etiology of the two episodes of 
aseptic meningitis in this patient.
To our knowledge, amoxicillin-induced aseptic   meningitis 
has been reported only six times in the literature; the 
last report was in 2008, and this will be the seventh well 
  documented case report dealing with such a severe side effect 
of a widely and popular antibiotic.
Methods, procedures and assays 
used for the diagnosis of aseptic 
meningitis
Several methods, procedures and assays are needed to estab-
lish fast and accurate diagnosis of aseptic meningitis. It is 
important to obtain a careful history of medical disorders such 
as systemic lupus erythematosus, the most frequent underlying 
condition associated with DIAM.3 In addition it is important 
to make inquiries about recent vaccinations that may be impli-
cated in the development of aseptic meningitis.24 It should 
take into account that patients who have DIAM, the typical 
CSF profile reveals a neutrophilic pleocytosis, with several 
hundred to several thousand white blood cells per microliter; 
normal glucose levels; and variably elevated protein levels.2,25 
Results of CSF Gram stain and cultures are negative, and 
lymphocytic or eosinophilic pleocytosis may occur.
Different tests include: laboratory diagnosis; PCR assay 
and variants reverse transcription polymerase chain reaction 
(RT-PCR) and Multiplex PCR; procalcitonin (PCT); viral 
isolation; serology and sometimes imaging are needed for 
adequate diagnosis of aseptic meningitis.
Many studies demonstrate the convenience of the applica-
tion of the molecular assays in the laboratory diagnosis of 
the meningoencephalitis of different etiology. Besides this, 
it is also a very valuable tool for the clinical management 
of the patients and for the execution of the epidemiological 
studies.26,27 Routine CSF enterovirus-specific polymerase 
chain reaction (EV-PCR) testing has been shown to reduce 
length of hospitalization in pediatric patients with suspected 
aseptic meningitis.28–30
Analysis of C-reactive protein (CRP) levels also may be 
helpful in distinguishing bacterial- from drug-induced aseptic 
meningitis because CRP levels are usually highly elevated 
in bacterial meningitis compared with DIAM.31,32
In our case report different diagnostic studies were per-
formed, in addition to complete medical history, physical 
examination and CT, the diagnostic work included blood 
and CSF examination and serology for infectious meningitis, 
viral culture of throat and rectal specimens was conducted 
in addition to serological tests for enteroviruses followed by 
herpes simplex PCR and enterovirus CSF PCR.
Discussion
DIAM still relatively infrequent but probably more frequent 





usage of different antibiotics; the list of medications that 
cause DIAM continues to increase and currently includes a 
wide variety of medications.2,3,33–58
DIAM continues to cause a clinical dilemma, because 
it can present as any other type of meningitis. Also, the 
empirical treatment may, in fact, be the offending agent; 
further confusing the physician involved in the care of the 
patient with DIAM.
Many classes of medications have been reported to 
cause DIAM, typically in patients known to have sys-
temic lupus erythematosus.3 The most common drugs 
are nonsteroidal anti-inflammatory drugs, antibiotics, 
intravenous immunoglobulin, and muromonab-CD3 mono-
clonal antibodies4–6 of the antibiotics, the most commonly 
reported offending agents include many antimicrobials, 
such as trimethoprim-sulfamethoxazole, ciprofloxacin, 
cephalexin, metronidazole, amoxicillin, penicillin, and 
isoniazid, are causes of aseptic meningitis. In addition, the 
xanthine oxidase inhibitor allopurinol has been implicated 
in causing aseptic meningitis. DIAM is a complication in 
which numerous other drugs, namely ranitidine, carbam-
azepine, vaccines against hepatitis B and mumps and OKT3 
monoclonal antibodies (ie, directed against the T3 recep-
tor and, therefore, pan T-cell antibodies), co-trimoxazole, 
radiographic agents, and muromonab-CD3, also have been 
associated.2,3,33–40   Amoxicillin is a moderate-spectrum, 
bacteriolytic, β-lactam antibiotic used commonly to treat 
bacterial infections caused by susceptible micro-organisms. 
It is usually the drug of choice within the class because it is 
better absorbed, following oral administration, than other 
β-lactam antibiotics.
Notwithstanding the wide use of this antibiotic, side 
effects were reported. Indeed, amoxicillin-induced aseptic 
meningitis has been reported only six times in the literature; 
the latest report was in 2008.32,42,43,59–61
Although there has been speculation of a type 3 hyper-
sensitivity reaction as a possible mechanism of amoxicillin-
induced aseptic meningitis, a study by Wittmann et al and 
Kastenbauer et al42,62 found no evidence of involvement of 
type 1 or type 3 reactions.
Regardless of its low frequency, aseptic meningitis is 
increasing and it can mimic an infectious process as well as 
meningitis that are secondary to systemic disorders for which 
these drugs are used. Therefore, it should be included in the 
differential diagnosis of aseptic meningitis, particularly if 
aseptic meningitis develops in association with the use of 
nonsteroidal anti-inflammatory drugs (NSAIDs)4,63 or other 
offending drugs and if clinical recovery is rapid following 
cessation of the drug or if results of viral studies are   negative. 
Indeed, the diagnosis of DIAM is made by establishing a 
chronological relationship with the administration of the 
drug, onset of clinical symptoms and rapid resolution of the 
syndrome after drug withdrawal.
The present case again helps shed some light on rare, 
morbid events that are attributable to commonly prescribed 
medications. Because clinical characteristics of DIAM mimic 
those of infectious or other types of meningitis, physicians 
must continue to take thorough histories and be aware of the 
various medications that could cause these illnesses.
Conclusion
We conclude that a thorough history on prior drug intake 
must be conducted in every case of meningitis, with special 
focus on those aforementioned drugs. If there is a suspicion of 
DIAM, a third-generation cephalosporin seems a reasonable 
treatment option until CSF cultures are available. We should 
keep in mind these recommendations:
1.  Quick resolution of symptoms is an important sign that 
distinguishes DIAM from viral meningitis, in which 
recovery usually requires 10 to 14 days. The diagnosis 
of DIAM is made by establishing a temporal relationship 
with the administration of the drug and onset of clinical 
symptoms and rapid resolution of the syndrome after drug 
withdrawal.
2.  CSF glucose levels are usually normal in DIAM, which 
may help in differentiating it from bacterial meningitis 
in which glucose levels usually are low.
3.  Analysis of CRP levels also may be helpful in distinguish-
ing bacterial from DIAM because CRP levels are usually 
highly elevated in bacterial meningitis compared with 
DIAM.
The clinical features of almost all cases of amoxicillin-
induced aseptic meningitis reported in the Table 1 are similar. 
All patients who have amoxicillin-induced aseptic meningitis 
typically present with fever, headache, and stiff or rigid neck. 
The time between use of the amoxicillin and onset of the signs 
and symptoms ranged from 2 to 7 days after drug ingestion. 
DIAM has been reported as an uncommon adverse reaction. 
DIAM is a diagnosis of exclusion, and clinical signs and CSF 
findings vary greatly. Clinical symptoms and CSF findings 
in patients with DIAM were indistinguishable from the early 
stage of infections of the CNS. Detailed anamnesis was 
essential, particularly related to medication used immediately 
prior to the appearance of symptoms of CNS impairment. 
Hence, the diagnosis of DIAM was done by establishing a 





and onset of clinical symptoms and rapid resolution of the 
syndrome after drug withdrawal.
In patients who have amoxicillin-induced aseptic 
meningitis, the typical CSF profile reveals a neutrophilic 
pleocytosis, with several hundred to several thousand white 
blood cells per microliter; normal glucose levels; and vari-
ably elevated protein levels. Results of CSF Gram stain and 
cultures were negative. Amoxicillin-induced aseptic menin-
gitis was reversible, with most signs and symptoms resolving 
within 24 to 48 hours after the drug were discontinued.
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